NIFTY23,4060.33%
SENSEX74,3460.41%
BANKNIFTY54,1860.88%
NIFTY IT29,3845.57%
PHARMA24,0870.33%
AUTO26,0930.05%
FMCG48,1241.01%
METAL13,5350.17%
REALTY762.601.39%
ENERGY40,1970.02%
NIFTY23,4060.33%
SENSEX74,3460.41%
BANKNIFTY54,1860.88%
NIFTY IT29,3845.57%
PHARMA24,0870.33%
AUTO26,0930.05%
FMCG48,1241.01%
METAL13,5350.17%
REALTY762.601.39%
ENERGY40,1970.02%

HDFC Mutual Fund Offloads 2% Stake in Sundram Fasteners

On March 4, HDFC Mutual Fund sold a 2.04% stake in Sundram Fasteners, a precision component manufacturer for various sectors, for approximately Rs 357.66 crore via open market transactions. The sale represents 20.5 lakh shares at Rs 831.97 per share and 22.48 lakh shares at Rs 832.36 per share.

Sundram Fasteners shares declined 1.3% to close at Rs 835.9 on the National Stock Exchange (NSE), amidst high trading volumes. This marks the sixth consecutive day of pressure on the stock.

HDFC Mutual Fund held a 7.62% stake in Sundram Fasteners as of December 2025, through its HDFC NIFTY500 Multicap 50:25:25 Index Fund.

Read also: Treasury Yields Experience Largest Increase in Two Weeks Following Release of Labor Market Data

PNGS Reva Diamond Jewellery experienced a significant surge, rising 6.66% to Rs 411.7 on the NSE, despite institutional investors selling a 1.49% stake in the company on its listing day. Asio Fund VCC-Sub Fund 4 and Vikasa India EIF I Fund - Share Class P each sold 2.36 lakh shares at Rs 375 per share, valued at Rs 8.87 crore.

Akme Fintrade (India) saw significant changes in its shareholder base, with Subhash Phootarmal Rathod acquiring 46 lakh shares at Rs 7.24 per share for Rs 3.33 crore. Meanwhile, Indian Infotech and Software sold 40 lakh shares at Rs 7.25 per share, valued at Rs 2.9 crore. Both companies already held a stake in Akme Fintrade (India), with 3.6% and 1.12% respectively.

Investor Takeaway

Investors should be cautious of HDFC Mutual Fund's sale of shares in Sundram Fasteners.

IPOScanner Logo

IPOScanner helps investors track upcoming, live and past IPOs in one place with GMP, subscription, allotment status and listing performance insights.

About IPO Scanner

IPOScanner is built for investors who want a clear view of every IPO opportunity in one place. From upcoming issues to live subscription data, allotment updates and listing performance, we bring together the key details you need to track the primary market.

Our tools are designed to be simple, fast and investor-friendly so you can focus on evaluating businesses instead of opening multiple tabs and websites for basic information.

Details of client bank account
For any query / feedback / clarifications, email at
[email protected].

Please read all offer documents and risk disclosures carefully before investing. IPOScanner does not provide investment advice and information on this site should not be treated as a recommendation to apply for any IPO.

© 2026 IPO Scanner. All rights reserved.